--- title: 'Market Development Director - Southeast Region at REGENXBIO' canonical: 'https://feeny.ai/job/market-development-director-southeast-region-regenxbio-remote-b1hhp987p5v1' type: 'job' last_seen: '2026-09-14' --- # Market Development Director - Southeast Region at REGENXBIO - **Company:** REGENXBIO - **Location:** Remote - **Employment:** full-time - **Work type:** remote - **Posted:** 2026-09-04 - **Last confirmed live:** 2026-09-14 - **Apply:** https://jobs.lever.co/regenxbio/32e49c7b-736a-4678-85de-d67e494b8712 ## Job description ## Who we are REGENXBIO is an exceptional place to work. You'll have the opportunity to collaborate with some of the best and the brightest people, touch amazing science, and be a part of extraordinary plans. Our core values: Trust, Accountability, Perseverance, and Innovation drive everything we do. We aim to bring these values to life every day with all that we do, and we believe that what we do matters - to patients, to their families, and to their communities. The opportunity As a Market Development Director, you will drive regional strategy and commercial launch readiness in support of our innovative therapies for rare and neuromuscular diseases. In this field-based leadership role, you'll lead strategic engagement with key stakeholders and treatment centers, ensuring regional alignment with REGENXBIO's broader go-to-market objectives. As a vital connection between internal teams, including Sales, Medical Affairs, Patient Services, Advocacy, Marketing, and Market Access—and external ecosystem partners, you'll shape and execute regional strategies that support treatment access and long-term market development for REGENXBIO's products. ## What you'll be doing - Develop and execute targeted engagement strategies for key accounts in assigned regions. - Establish REGENXBIO as a trusted partner in the neuromuscular and rare disease communities. - Lead regional business planning aligned with corporate goals and cross-functional priorities. - Collaborate with internal stakeholders to synthesize customer insights, inform strategic decisions, and optimize messaging and programs. - Ensure adequate resource allocation to drive regional business success. - Identify, educate and align thought leaders to our strategic imperatives while being accountable for pulling through brand initiatives with the thought leaders. - Profile treatment centers to assess readiness, patient care models, referral patterns, and logistical infrastructure. - Deliver education on REGENXBIO’s products, and tend to end treatment administration logistics. - Identify and address barriers to care, including infusion capacity, billing/coding challenges, and payer dynamics. - Support reimbursement readiness and validate regional processes for market access. - Cultivate strategic partnerships and referral networks to support launch and market expansion. - Define and track KPIs to measure launch execution quality and speed. - Serve as the primary point of contact for assigned treatment centers, experts, and stakeholders. - Drive brand awareness, engagement, and treatment adoption through innovative commercial strategies. - Monitor regional trends in the competitive, regulatory, and payer landscapes to inform strategy. - Champion a customer-first mindset and ensure execution reflects the needs of patients and providers. - It is imperative that REGENXBIO employees embody our core values by working collaboratively, building strong relationships and using clear communication to meet shared objectives. ## What we’re looking for - Minimum of 5+ years in a commercial, market development, or strategic customer engagement role within biotech/pharma. - Bachelor’s degree required (BA/BS); advanced degree (MBA, PhD, PharmD) strongly preferred - Proven track record in the rare disease space, ideally including neuromuscular indications. - Experience supporting new product launches in complex therapeutic areas. - Strong understanding of U.S. healthcare dynamics, market access, and reimbursement pathways. - Familiarity with account-based models and stakeholder mapping in specialty care. - Analytical thinker with the ability to extract insights from data and apply them to commercial decisions. - Excellent communication and stakeholder management skills. - Strategic mindset with the ability to align cross-functional teams toward shared goals. - High ethical standards, integrity, and a mission-driven approach. - Ability to thrive in a fast-paced, entrepreneurial environment. - Strong initiative and problem-solving capabilities. - Willingness and flexibility to travel up to 60% for stakeholder engagements. Why should you apply? By joining REGENXBIO, you will have the opportunity to be a part of a growing company, with an incredible team, who is passionate about developing novel AAV gene therapies for patients in need. We offer a comprehensive and competitive benefit & compensation package which includes market-competitive salaries, an annual bonus program, education assistance, retirement plan with employer match, stock options at all levels, summer hours and more! The estimated compensation range for this role is $187,000 to $265,000 annually. The actual salary offered to the final candidate depends on a number of factors such as relevant work experience, skills, education, and years of experience. In addition, professional development is important to us.  By joining our team, you’ll have the opportunity to be exposed to challenging projects and have access to development resources to help you grow personally and professionally. ## About REGENXBIO ## Company Overview - **One-liner**: REGENXBIO is a clinical-stage biotechnology company developing one-time gene therapies for rare and retinal diseases using its proprietary AAV vector platform. - **Entity Type**: Public (NASDAQ: RGNX) - **Headquarters**: Rockville, Maryland, United States - **Founded**: 2008 (founded as a company; operations began in 2009) - **Founders**: Not publicly listed as individual founders; the company was spun out from the gene therapy research of the University of Pennsylvania and licensed its NAV Technology Platform from the university. ## Core Business - **Primary industry**: Biotechnology – Gene Therapy (AAV-based) - **Target customers**: B2B (pharma partners like AbbVie, Nippon Shinyaku) and B2G (regulatory agencies, clinical trial sites); ultimate customers are patients with rare and retinal diseases (Duchenne muscular dystrophy, MPS I, MPS II, wet AMD, diabetic retinopathy). - **Mission or purpose statement**: “To improve lives through the curative potential of gene therapy.” [regenxbio.com](https://www.regenxbio.com/culture-careers/) ## Products & Services - **NAV® Technology Platform**: Proprietary AAV vector gene delivery platform (including AAV8 and AAV9) used for internal programs and licensed to partners (e.g., Novartis for ZOLGENSMA®). - **ABBV-RGX-314** (in collaboration with AbbVie): Investigational one-time gene therapy for wet age-related macular degeneration (wet AMD) and diabetic retinopathy (DR). In pivotal clinical trials. - **RGX-202** (Duchenne muscular dystrophy): Phase I/II/III AFFINITY DUCHENNE® trial; pivotal phase expected to support BLA submission in 2026 using accelerated approval pathway. [ir.regenxbio.com](https://ir.regenxbio.com/static-files/92731f97-50e3-4285-b793-d2cdc99611aa) - **RGX-121** (MPS II – Hunter syndrome): In partnership with Nippon Shinyaku; late-stage development. - **RGX-111** (MPS I – Hurler syndrome): In partnership with Nippon Shinyaku; clinical development. - **Manufacturing**: In-house cGMP production facility (REGENXBIO Manufacturing Innovation Center – RMIC) in Rockville, MD, operational since mid-2022. ## Market Standing - **Valuation/Market Cap**: $447.8 million (as of recent data). [linkedin.com](https://linkedin.com/company/regenx) - **Key Metric**: Annual Revenue $170.4 million (primarily from license and collaboration revenue). [linkedin.com](https://linkedin.com/company/regenx) - **Notable Investors/Partners**: - AbbVie (collaboration for ABBV-RGX-314) - Nippon Shinyaku (partnerships for RGX-121 and RGX-111) - Novartis (licensee for ZOLGENSMA® using NAV vectors) - **Growth Signals**: - Headcount: 296 employees (+1.3% YoY). [linkedin.com](https://linkedin.com/company/regenx) - BLA submission for RGX-202 targeted for 2026. - RMIC facility operational since 2022, enabling scalable clinical and commercial manufacturing. - Scholarly output: 160 works, 7,337 citations, field-weighted citation impact of 2.6 (highly influential). [linkedin.com](https://linkedin.com/company/regenx) ## Competitive Advantages - **Proprietary NAV Technology Platform**: Exclusive rights to a large portfolio of AAV vectors (including AAV8 and AAV9), the foundation for multiple approved and investigational gene therapies. [ir.regenxbio.com](https://ir.regenxbio.com/static-files/92731f97-50e3-4285-b793-d2cdc99611aa) - **End-to-end capabilities**: Integrated in-house R&D, preclinical development, clinical development, and cGMP manufacturing. - **Proven platform**: Thousands of patients have been treated with AAV vectors from the NAV platform (including via Novartis’ ZOLGENSMA®). - **Late-stage pipeline**: Multiple programs in pivotal or near-pivotal trials (RGX-202, ABBV-RGX-314) with clear regulatory pathways. ## Strategic Focus - **Near-term**: Advance RGX-202 toward BLA submission in 2026; continue pivotal trials for ABBV-RGX-314 in wet AMD and diabetic retinopathy. - **Long-term**: Expand pipeline in retinal, neuromuscular, and neurodegenerative diseases; leverage RMIC for commercial-scale manufacturing; deepen partnerships with AbbVie and Nippon Shinyaku. - **Platform expansion**: Ongoing research to expand NAV vector capabilities and develop new AAV-based therapies. ## Why Work Here - **Mission-driven culture**: “Patient-focused, driven by results, fosters collaboration.” Core values emphasize accountability, innovation, and serving patients with limited therapeutic options. [regenxbio.com](https://www.regenxbio.com/culture-careers/) - **Impactful work**: Opportunity to work on one-time gene therapies that could fundamentally alter the course of devastating diseases. - **Growth & stability**: Public company with late-stage pipeline, strong partnerships, and a clear path to commercialization. - **Location & facilities**: Headquarters in Rockville, MD, with a state-of-the-art cGMP manufacturing facility (RMIC) on site. - **Work policy**: Not explicitly stated as remote/hybrid; positions appear to be on-site (based on job listings in Rockville and field-based Medical Science Liaison roles). - **Perks**: Comprehensive and competitive benefits for employees and families. [regenxbio.com](https://www.regenxbio.com/culture-careers/) - **Engineering & science culture**: High scholarly output and citation impact; emphasis on cross-functional collaboration between research, manufacturing, and clinical teams. - **Recruitment note**: REGENXBIO warns of fraudulent job offers; all applications go through their official Lever portal. [regenxbio.com](https://www.regenxbio.com/culture-careers/) ## Sources 1. [regenxbio.com – Culture & Careers](https://www.regenxbio.com/culture-careers/) 2. [linkedin.com – REGENXBIO company page](https://linkedin.com/company/regenx) 3. [ir.regenxbio.com – 10-K Filing (Business Overview)](https://ir.regenxbio.com/static-files/92731f97-50e3-4285-b793-d2cdc99611aa) 4. [ir.regenxbio.com – Investor Overview](https://ir.regenxbio.com/investor-overview) 5. [jobs.lever.co – REGENXBIO careers](https://jobs.lever.co/regenxbio) ## Other roles at REGENXBIO - [Associate Director, People Business Partner](https://feeny.ai/job/associate-director-people-business-partner-regenxbio-rockville-fmx3gbzx681y) — Rockville, MD - [Director, Commercial Data, Advanced Analytics & Forecasting](https://feeny.ai/job/director-commercial-data-advanced-analytics-forecasting-regenxbio-remote-88y6fvc5kv5j) - [Associate Director, Rare Disease Product Marketing](https://feeny.ai/job/associate-director-rare-disease-product-marketing-regenxbio-rockville-r2p05phcvmx8) — Rockville, MD - [Associate Director, Data & Information Architecture](https://feeny.ai/job/associate-director-data-information-architecture-regenxbio-rockville-b0m5vrmrm33p) — Rockville, MD - [Senior Medical Science Liaison - DMD/Neuromuscular (South)](https://feeny.ai/job/senior-medical-science-liaison-dmd-neuromuscular-south-regenxbio-remote-4qggqdykm9ym) - [Senior Medical Science Liaison - DMD/Neuromuscular (Northeast)](https://feeny.ai/job/senior-medical-science-liaison-dmd-neuromuscular-northeast-regenxbio-remote-47qpcgnnyhpc) - [Senior Medical Science Liaison - DMD/Neuromuscular (West Coast)](https://feeny.ai/job/senior-medical-science-liaison-dmd-neuromuscular-west-coast-regenxbio-west-coast-yerem2kwy7ca) — West Coast - [Senior Director, Global Program Development Lead - DMD/Neuromuscular](https://feeny.ai/job/senior-director-global-program-development-lead-dmd-neuromuscular-regenxbio-xbereeg0zrc8) — Rockville, MD - [Senior Director/Director, Medical Science Liaisons (Neuromuscular/DMD)](https://feeny.ai/job/senior-director-director-medical-science-liaisons-neuromuscular-dmd-regenxbio-aeca83gb75e2)